Skip to main content

Fan Yu

SEC CIK
0001668029
Latest filing
Aug 14, 2026

Holdings in Q2 2024

Holdings as of Jun 30, 2024, filed Aug 14, 2024. Long positions only; changes compare share counts with Q1 2024.

Institution overview
Positions
6
+1 vs. Q1 2024
Portfolio value
$76.5M
+$3.99M (+5.5%) vs. Q1 2024
Filed
Aug 14, 2024
SEC
Holdings of Fan Yu in Q2 2024
SecurityClassSharesValue% of portfolioShare changeActionHistory
CGONCG Oncology, Inc.COM1,578,344$49.8M65.1%+1,578,344NewHistory
CRGXCARGO Therapeutics, Inc.COM912,000$15.0M19.6%+912,000NewHistory
ALMSAlumis Inc.COM789,618$10.5M13.7%+789,618NewHistory
CSTLCastle Biosciences IncCOM36,747$800.0K1.0%+36,747NewHistory
PYXSPyxis Oncology, Inc.COMMON STOCK69,303$229.4K0.3%00.0%UnchangedHistory
SGMTSagimet Biosciences Inc.COM SER A57,190$195.6K0.3%00.0%UnchangedHistory

Sold out since Q1 2024 (3)

Positions held at the end of Q1 2024 that are gone from this filing.

Positions of Fan Yu sold out since Q1 2024
SecurityClassShares in Q1 2024Value in Q1 2024% of portfolio in Q1 2024History
PREPrenetics Global LtdCLASS A ORD1,252,438$55.0M75.8%History
SYRESpyre Therapeutics, Inc.COM737,000$16.4M22.7%History
SONXSonendo, Inc.COM22,503$498.4K0.7%History